One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Issue Highlights page
doi : 10.1016/S0360-3016(22)03575-1
Volume 115, Issue 2, 1 February 2023, Pages A9-A12
Recent Key Studies in Cancers of the Uterine Corpus and Cervix: New Updates in Immunotherapy, the Microbiome, Bone Density, Quantifying Lymphovascular Invasion, and Hypofractionated Pelvic Radiation Therapy.
Matthew Harkenrider,* Emma Fields,y Supriya Chopra,z Shari Damast,x Elizabeth A. Kidd,â•‘ and Junzo Chino
doi : 10.1016/j.ijrobp.2022.07.1833
Volume 115, Issue 2, 1 February 2023, Pages 269-275
Bulky, Solitary Hepatocellular Carcinoma
Abhinav V. Reddy, MD, and Jeffrey Meyer, MD
doi : 10.1016/j.ijrobp.2022.08.001
Volume 115, Issue 2, 1 February 2023, Page 276
HCC: We Prefer Fractionation Versus Dose Reduction
Carla Hajj, MD Christopher H. Crane, MD
doi : 10.1016/j.ijrobp.2022.08.061
Volume 115, Issue 2, 1 February 2023, Page 277
“New� Kid on the Block: Interstitial Brachytherapy
Stefanie Corradini, MDMax Seidensticker, MD
doi : 10.1016/j.ijrobp.2022.08.060
Volume 115, Issue 2, 1 February 2023, Pages 277-279
Start Combining, Stop Comparing
Jason K. Molitoris, MD, PhD
doi : 10.1016/j.ijrobp.2022.08.058
Volume 115, Issue 2, 1 February 2023, Page 279
Radiation Segmentectomy—Ablative and Conformal Radiation Therapy With High Rates of Complete Pathologic Response
Beau Toskich, MD FSIRSunil Krishnan, MBBS MD
doi : 10.1016/j.ijrobp.2022.08.062
Volume 115, Issue 2, 1 February 2023, Pages 279-280
The American Society for Radiation Oncology Workforce Statement
Chirag Shah, MD,* Pranshu Mohindra, MD,y Neha Vapiwala, MD,z Shauna Campbell, DO,* James Edward Bates, MD,x Malcolm D. Mattes, MD,k Austin Sim, MD,� Hiral P. Fontanilla, MD, # Emma Fields, MD,** Chelsea C. Pinnix, MD, PhD,yy and Bruce Haffty, MD
doi : 10.1016/j.ijrobp.2022.08.032
Volume 115, Issue 2, 1 February 2023, Pages 281-284
The Accreditation Council for Graduate Medical Education's Recent Changes to Radiation Oncology Training Program Standards: Raising the Bar for Postgraduate Training Quality to Better Reflect Our Specialty and Better Serve Our Patients
Neha Vapiwala, MD,* Michael Steinberg, MD,y and Cheryl Gross, MA, CAE
doi : 10.1016/j.ijrobp.2022.07.033
Volume 115, Issue 2, 1 February 2023, Pages 285-287
Characteristics of the Association of Residents in Radiation Oncology Educator of the Year Award Recipients
Anna Lee, MD, MPH,* Kathryn E. Marqueen, MD,* and Suzanne B. Evans, MD, MPH
doi : 10.1016/j.ijrobp.2022.05.049
Volume 115, Issue 2, 1 February 2023, Pages 288-293
The Art of Radiation Therapy: The Necessary Risk of Radiation Necrosis for Durable Control of Brain Metastases
Michael T. Milano, MD, PhD,* Scott G. Soltys, MD,y Lawrence B. Marks, MD,z Dwight E. Heron, MD,x Ellen Yorke, PhD,â•‘ Jimm Grimm, PhD,{ Andrew Jackson, PhD,â•‘ Alina Mihai, MD, # Robert D. Timmerman, MD,** Jinyu Xue, PhD,yy Brian D. Kavanagh, MD,zz and Kristin J. Redmond, MD
doi : 10.1016/j.ijrobp.2022.07.036
Volume 115, Issue 2, 1 February 2023, Pages 294-296
Stereotactic Body Radiation Therapy for Nodal Metastases in Gynecologic Cancers: Is it the Swan Song or the Opening Number?
Lara Hathout, MD,* Emma C. Fields, MD,y and Beth A. Erickson, MD
doi : 10.1016/j.ijrobp.2022.07.1836
Volume 115, Issue 2, 1 February 2023, Pages 297-301
Improving Treatment Interventions and Cancer Outcomes in Persons Experiencing Homelessness: A Population Underrepresented in Equity Initiatives
Zachary S. Mayo, MD,* Shauna R. Campbell, DO,* Chirag S. Shah, MD,* Jeremy Weleff, DO,y,z and Sarah S. Kilic, MD
doi : 10.1016/j.ijrobp.2022.09.059
Volume 115, Issue 2, 1 February 2023, Pages 302-304
Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: 5-Year Efficacy and Toxicity in the DELINEATE Trial
Alison C. Tree, MD,*,y Laura Satchwell, MSc,* Emma Alexander, FRCR,* Irena Blasiak-Wal, MSc,* Nandita M deSouza, FRCR,y Annie Gao, MSc,* Emily Greenlay, MSc,* Helen McNair, PhD,*,y Chris Parker, FRCR,* ,y James Talbot, MSc,* David Dearnaley, FRCR,y, * and Julia Murray, FRCR
doi : 10.1016/j.ijrobp.2022.09.058
Volume 115, Issue 2, 1 February 2023, Pages 305-316
Metformin for Prevention of Anthropometric and Metabolic Complications of Androgen Deprivation Therapy in Prostate Cancer Patients Receiving Radical Radiotherapy: A Phase II Randomized Controlled Trial
Nawaid Usmani, MD,* Sunita Ghosh, PhD,y Karan P. Sanghera, MD,* Aldrich D. Ong, MD, MSc,z Rashmi Koul, MD,z Arbind Dubey, MD,z Shahida Ahmed, MD,z Harvey Quon, MD,x Don Yee, MD,* Matthew Parliament, MD,* Gokulan Sivananthan, MD,z,k William Hunter, MD,z,k Brita Danielson, MD,* Lindsay Rowe, MD,* Megan McDonald, MD,z and Julian O. Kim, MD, MSc
doi : 10.1016/j.ijrobp.2022.07.035
Volume 115, Issue 2, 1 February 2023, Pages 317-326
The Fraction Size Sensitivity of Late Genitourinary Toxicity: Analysis of Alpha/Beta (α/β) Ratios in the CHHiP Trial
Douglas H. Brand, PhD,*,y,z Sarah C. Br€uningk, PhD,x,║ Anna Wilkins, PhD,*,y Olivia Naismith, MSc,{ Annie Gao, MSc,* ,y Isabel Syndikus, MD, # David P. Dearnaley, FRCR,*,y Nicholas van As, FRCR,*,y Emma Hall, PhD,** Sarah Gulliford, PhD,z,yy and Alison C. Tree, MD(Res)*,y On behalf of the CHHiP Trial Management Group
doi : 10.1016/j.ijrobp.2022.08.030
Volume 115, Issue 2, 1 February 2023, Pages 327-336
Analysis of Local Control Outcomes and Clinical Prognostic Factors in Localized Pelvic Ewing Sarcoma Patients Treated With Radiation Therapy: A Report From the Children's Oncology Group
Safia K. Ahmed, MD,* Brent G. Witten, MD,y William S. Harmsen, MS,z Peter S. Rose, MD,x Mark Krailo, PhD,â•‘ Karen J. Marcus, MD,{ R. Lor Randall, MD, # Steven G. DuBois, MD, ** Katherine A Janeway, MD, ** Richard B. Womer, MD,yy Holcombe E. Grier, MD, ** Richard G. Gorlick, MD,zz and Nadia N.I. Laack, MD, MS
doi : 10.1016/j.ijrobp.2022.07.1840
Volume 115, Issue 2, 1 February 2023, Pages 337-346
Effect of 3-Dimensional Interstitial High-Dose-Rate Brachytherapy With Regional Metastatic Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: 5-Year Follow-up of a Phase 2 Clinical Trial
Li Xiang, PhD,a Pei-Rong Ren, MD, a Hong-Xia Li, MD, Hua Ye, MD, Hao-Wen Pang, MD, Qing-Lian Wen, PhD, Jian-Wen Zhang, MD, Li-Jia He He, MD, Chang-Ling Shang, MD, Bo Yang Yang, MD, Sheng Lin Lin, PhD, and Jing-Bo Wu Wu, MD
doi : 10.1016/j.ijrobp.2022.07.028
Volume 115, Issue 2, 1 February 2023, Pages 347-355
Xenon-Enhanced Ventilation Computed Tomography for Functional Lung Avoidance Radiation Therapy in Patients With Lung Cancer
Yu-Sen Huang, MD, PhD,*,y Jenny Ling-Yu Chen, MD, PhD,*,z Hao-Ting Lan, MS,z Mei-Hwa Tai, MS,*,y Sung-Hsin Kuo, MD, PhD,x,z Jin-Yuan Shih, MD, PhD,x and Yeun-Chung Chang, MD, PhD
doi : 10.1016/j.ijrobp.2022.07.034
Volume 115, Issue 2, 1 February 2023, Pages 356-365
Cardiac Substructures Dosimetric Predictors for Cardiac Toxicity After Definitive Radiotherapy in Esophageal Cancer
Guoxin Cai, MD,*,y Chuanbao Li, MD, PhD,z,x Jisheng Li, MD, PhD,â•‘ Jianmin Yang, MD, PhD,x Chengming Li, MD,y Liangchao Sun, MD,y Jianing Li, BS,y Jinming Yu, MD, PhD,y and Xue Meng, MD, PhD*,
doi : 10.1016/j.ijrobp.2022.08.013
Volume 115, Issue 2, 1 February 2023, Pages 366-381
Clinical Outcome-Related Cancer Pathways and Mutational Signatures in Patients With Unresectable Esophageal Squamous Cell Carcinoma Treated With Chemoradiotherapy
Li Li, MD, PhD,* Jujie Sun, MD,y Ning Liu, MD,* Ruoying Yu, PhD,z Junli Zhang, MS, z Jiaohui Pang, MS,z Qiuxiang Ou, PhD,z Ying Yin, MD,* Jinfeng Cui, MD,* Xuling Yao, BS,y Ranran Zhao, BS,y Yang Shao, PhD,z,x Shuanghu Yuan, MD, PhD,*,# and Jinming Yu, MD, PhD*
doi : 10.1016/j.ijrobp.2022.07.1835
Volume 115, Issue 2, 1 February 2023, Pages 382-394
The Role of Dose Escalation in Pancreatic Cancer: Go Big or Go Home?
Joshua E. Meyer, MD,* and Jordan Kharofa, MD
doi : 10.1016/j.ijrobp.2022.09.050
Volume 115, Issue 2, 1 February 2023, Pages 395-397
Serial Measurement of Global Longitudinal Strain Among Women With Breast Cancer Treated With Proton Radiation Therapy: A Prospective Trial for 70 Patients
Malek Z.O. Hassan, MD,*,y Magid Awadalla, MD,*,z,x Timothy C. Tan, MD, PhD,â•‘ Marielle Scherrer-Crosbie, MD, PhD,{ Rula Bany Bakar, MD, PhD,* Zsofia D. Drobni, MD,* Azmaeen Zarif, BA,y Hannah K Gilman, BS,* Sama Supraja, BS,* Sofia Nikolaidou, BS,* Lili Zhang, MD, MS,* ,z Daniel A. Zlotoff, MD, PhD,* Shea B. Hickey, BS, # Sagar A. Patel, MD, # James L. Januzzi, MD,** Florence Keane, MD, # Jonathon J. Passeri, MD,** Tomas G. Neilan, MD, MPH,*,z Shannon M. MacDonald, MD, # and Rachel B. Jimenez, MD
doi : 10.1016/j.ijrobp.2022.08.036
Volume 115, Issue 2, 1 February 2023, Pages 398-406
Gut Microbiome Is Associated With the Response to Chemoradiotherapy in Patients With Non-small Cell Lung Cancer
Bo Qiu, MD,* Yu Xi, PhD,y,z FangJie Liu, MD,* Ying Li, PhD,y XinQiang Xie, PhD,y JinYu Guo, MS,* SuPing Guo, MS,* YingJia Wu, MS,* Lei Wu, PhD,y TingTing Liang, PhD,y Yu Ding, PhD,y Jumei Zhang, PhD,y QingPing Wu, PhD,y,1 and Hui Liu, MD*
doi : 10.1016/j.ijrobp.2022.07.032
Volume 115, Issue 2, 1 February 2023, Pages 407-418
Unravelling the Potential of Lutetium-177 Labeled Pertuzumab: Targeting HER 2 Receptors for Theranostic Applications
Rohit Sharma, MSc,*,y Archana Mukherjee, PhD,*,y Jyotsna Bhatt Mitra, MSc,*,y and Haladhar Dev Sarma, PhD
doi : 10.1016/j.ijrobp.2022.07.029
Volume 115, Issue 2, 1 February 2023, Pages 419-425
Evaluation of the Role of the Immune System Response After Minibeam Radiation Therapy
Annaig Bertho, PhD,*,y,1 Lorea Iturri, PhD,*,y,1 Elise Brisebard, MSc,z Marjorie Juchaux, PhD,*,y Cristele Gilbert, MSc,*,y Ramon Ortiz, MSc,* ,y Catherine Sebrie, PhD,x Laurene Jourdain, MSc,x Charlotte Lamirault, PhD,k Gabriel Ramasamy, MSc,k Frederic Pouzoulet, PhD,k,{ and Yolanda Prezado, PhD
doi : 10.1016/j.ijrobp.2022.08.011
Volume 115, Issue 2, 1 February 2023, Pages 426-439
Ionizing Radiation Triggers the Antitumor Immunity by Inducing Gasdermin E-Mediated Pyroptosis in Tumor Cells
Wei Cao, MPhil,*,y Guodong Chen, PhD,*,z Lijun Wu, PhD,x K.N. Yu, PhD,â•‘,# Mingyu Sun, BA,*,{ Miaomiao Yang, MPhil,* Yanyi Jiang, PhD,* Yuan Jiang, PhD,* Yuan Xu, MPhil,*,y Shengjie Peng, MPhil,*,y and Wei Han, PhD
doi : 10.1016/j.ijrobp.2022.07.1841
Volume 115, Issue 2, 1 February 2023, Pages 440-452
Spatial Gene Expression Changes in the Mouse Heart After Base-Targeted Irradiation
Gerard M. Walls, FRCR,*,y Mihaela Ghita, PhD,* Rachel Queen, PhD,z Kevin S. Edgar, PhD,x Eleanor K. Gill, PhD,x,k Refik Kuburas, PhD,* David J. Grieve, PhD,x Chris J. Watson, PhD,x Alan McWilliam, PhD,{,# Marcel Van Herk, PhD,{,# Kaye J. Williams, PhD,** Aidan J. Cole, FRCR, PhD,*,y Suneil Jain, FRCR, PhD,*,y and Karl T. Butterworth, PhD
doi : 10.1016/j.ijrobp.2022.08.031
Volume 115, Issue 2, 1 February 2023, Pages 453-463
Association of T Cell Senescence with Radiation Pneumonitis in Patients with Non-small Cell Lung Cancer
Kyung Hwan Kim, 1, * Hongryull Pyo, 2, * Hoyoung Lee, 3 Dongryul Oh,2 Jae Myoung Noh, 2 Yong Chan Ahn,2 Chang Gon Kim, 4 Hong In Yoon, 1 Jiyun Lee,4,5 Sehhoon Park, 5 Hyun-Ae Jung, 5 Jong-Mu Sun, 5 Se-Hoon Lee, 5 Jin Seok Ahn, 5 Keunchil Park, 5 Bo mi Ku, 6 Eui-Cheol Shin,3,y and Myung-Ju Ahn,
doi : 10.1016/j.ijrobp.2022.07.018
Volume 115, Issue 2, 1 February 2023, Pages 464-475
Inhibiting the Cytosolic Phospholipase A2–Arachidonic Acid Pathway With Arachidonyl Trifluoromethyl Ketone Attenuates Radiation-Induced Lung Fibrosis
Pengxiang Chen, MD,*,y Hui Liu, MD,z Huixian Xin, MD,* Bo Cheng, MD,x Changhua Sun, PhD,â•‘ Yuchen Liu, MD,* Tianyu Liu, MD,* Zhihua Wen, PhD,* and Yufeng Cheng, PhD*
doi : 10.1016/j.ijrobp.2022.03.008
Volume 115, Issue 2, 1 February 2023, Pages 476-489
Irradiation-Induced Intestinal Injury is Associated With Disorders of Bile Acids Metabolism
Li Guo, PhD,* Fei Da, PhD,*,y Qiaohui Gao, MD,* Xia Miao, PhD,* Juan Guo, PhD,* Wei Zhang, MD,* Jing Li, PhD,* Jin Wang, PhD,* and Junye Liu, PhD
doi : 10.1016/j.ijrobp.2022.08.007
Volume 115, Issue 2, 1 February 2023, Pages 490-500
A Systematic Comparison of Dose Distributions Delivered in 125I Plaque Brachytherapy and Proton Radiation Therapy for Ocular Melanoma
Alexei V. Trofimov, PhD,* Mary E. Aronow, MD,y Evangelos S. Gragoudas, MD,y Florence K. Keane, MD,* Ivana K. Kim, MD,y Helen A. Shih, MD,* and Mandar S. Bhagwat, PhD
doi : 10.1016/j.ijrobp.2022.07.017
Volume 115, Issue 2, 1 February 2023, Pages 501-510
Accurate and Early Metastases Diagnosis in Live Animals With Multimodal X-ray and Optical Imaging
Jiahao Chen, BS,* Ning Zhao, PhD,* Valeria Copello, BS,y Yi Ru, BS,z Kerry L. Burnstein, PhD,y,x and Yidong Yang, PhD
doi : 10.1016/j.ijrobp.2022.07.1832
Volume 115, Issue 2, 1 February 2023, Pages 511-517
Bone Marrow Relative Biological Effectiveness for a 212Pb-labeled Anti-HER2/neu Antibody
Ioanna Liatsou, PhD,* Anders Josefsson, PhD,y Jing Yu, PhD,* Angel Cortez, BSc,y Remco Bastiaannet, PhD,* Esteban Velarde, BSc,z Kaori Davis, DVM, PhD,x Cory Brayton, DVM,x Hao Wang, PhD,k Julien Torgue, PhD,{ Robert F. Hobbs, PhD,z and George Sgouros, PhD
doi : 10.1016/j.ijrobp.2022.07.1842
Volume 115, Issue 2, 1 February 2023, Pages 518-528
Automated Lung Cancer Segmentation Using a PET and CT Dual-Modality Deep Learning Neural Network
Siqiu Wang, MS,* Rebecca Mahon, PhD,y Elisabeth Weiss, MD,* Nuzhat Jan, MD,* Ross James Taylor, MD,* Philip Reed McDonagh, MD,* Bridget Quinn, MD,* and Lulin Yuan, PhD*
doi : 10.1016/j.ijrobp.2022.07.2312
Volume 115, Issue 2, 1 February 2023, Pages 529-539
In Regard to Chopade et al
Shaakir Hasan, DOJ. Isabelle Choi, MDArpit Chhabra, MDRobert H. Press, MDCharles B. Simone, II, MD
doi : 10.1016/j.ijrobp.2022.10.007
Volume 115, Issue 2, 1 February 2023, Pages 540-541
In Reply to Hasan et al
Charles B. Simone, II, MDPradnya Chopade, MDSupriya Chopra, MD
doi : 10.1016/j.ijrobp.2022.10.005
Volume 115, Issue 2, 1 February 2023, Pages 541-542
Erratum to: Tward, J; Lenz, L; Flake II, DD; Rajamani, S; Yonover, P; Olsson, C; Kapoor, DA; Mantz, C; Liauw, SL; Antic, T; Fabrizio, M; Salzstein, D; Shore, N; Albertson, D; Henderson, J; Lee, SP; Gay, HA; Michalski, J; Hung, A; Raben, D; Garraway, I; Lewis, MS; Nguyen, PL; Marshall, DT; Brawer, MK; Stone, S; Cohen, T. The clinical cell-cycle risk (CCR) score is associated with metastasis after radiation therapy and provides guidance on when to forgo combined androgen deprivation therapy with dose-escalated radiation. Int J Radiat Oncol Biol Phys 2022;113:66–76. doi.org/10.1016/j.ijrobp.2021.09.034
doi : 10.1016/j.ijrobp.2022.09.070
Volume 115, Issue 2, 1 February 2023, Page 543
